Biopharma companies need to recognize and view patient engagement through the perspective of the patient, allowing the individual to be the navigator of their personal journey - bridging gaps and leveraging connectivity both within, and outside of, the healthcare ecosystem.
In this paper, we highlight how:
- Drivers across the market are influencing how and why companies need to reimagine patient engagement.
- How scientific insights are yielding valuable understanding into what drives behavior and decision making throughout the patient journey.
- Key elements to consider in program design and the new engagement model – viewing the patient as an individual, focusing on activation, creating an engaging relationship, and leveraging partnerships to enable a patient-centric ecosystem.